In addition, treatment with the proteasome inhibitor MG132 obviously increased NNMT protein level, and rescued PRDX6 KO‐mediated decrease of NNMT protein level in ovarian cancer cells (Figure 4B). This evidence concerns the gene NNMT and ovarian carcinoma.